Market openADR
Belite Bio Inc. ADS/$BLTE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Belite Bio Inc. ADS
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Ticker
$BLTE
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
25
ISIN
US07782B1044
Website
BLTE Metrics
BasicAdvanced
$2B
-
-$1.37
-
-
Price and volume
Market cap
$2B
52-week high
$70.99
52-week low
$49.00
Average daily volume
32K
Financial strength
Current ratio
25.981
Interest coverage (TTM)
-2,359.25%
Management effectiveness
Return on assets (TTM)
-22.23%
Return on equity (TTM)
-33.43%
Valuation
Price to book
12.5
Price to tangible book (TTM)
12.5
Growth
Earnings per share change (TTM)
20.58%
3-year earnings per share growth (CAGR)
16.72%
BLTE News
AllArticlesVideos
Belite Bio, Inc (BLTE) Q1 2025 Earnings Call Transcript
Seeking Alpha·5 hours ago
Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewsWire·2 days ago
Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th
GlobeNewsWire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Belite Bio Inc. ADS stock?
Belite Bio Inc. ADS (BLTE) has a market cap of $2B as of May 15, 2025.
What is the P/E ratio for Belite Bio Inc. ADS stock?
The price to earnings (P/E) ratio for Belite Bio Inc. ADS (BLTE) stock is 0 as of May 15, 2025.
Does Belite Bio Inc. ADS stock pay dividends?
No, Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Belite Bio Inc. ADS dividend payment date?
Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders.
What is the beta indicator for Belite Bio Inc. ADS?
Belite Bio Inc. ADS (BLTE) does not currently have a Beta indicator.